Yeong Woong Kim

Title: Yeong Woong Kim: Innovator in Nucleic Acid Technologies

Introduction

Yeong Woong Kim is a prominent inventor based in Taegu, South Korea. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acids and their applications in diagnosing and treating diseases.

Latest Patents

Yeong Woong Kim holds a patent for "Nucleic acids encoding BDP-1." This patent encompasses nucleic acid molecules that encode full-length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides. It includes portions of these nucleic acid molecules, nucleic acid vectors containing them, and recombinant cells that house these vectors. The patent also covers polypeptides purified from such recombinant cells, antibodies to these polypeptides, and methods for identifying compounds that bind to these polypeptides or disrupt their interactions with natural binding partners. Furthermore, it outlines methods for diagnosing abnormal conditions in organisms related to PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP molecules or compounds.

Career Highlights

Yeong Woong Kim is associated with the Max Planck Society for the Advancement of Science, a prestigious research institution known for its cutting-edge scientific research. His work has been instrumental in advancing our understanding of nucleic acids and their potential therapeutic applications.

Collaborations

He has collaborated with notable scientists such as Axel Ullrich and Naohito Aoki, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Yeong Woong Kim's innovative work in nucleic acid technologies has the potential to significantly impact the diagnosis and treatment of various diseases. His contributions continue to pave the way for advancements in molecular biology and therapeutic applications.